1. ×àùèí Â.Ï. Áèîìîíèòîðèíã â îöåíêå ðèñêà, ðàçâèòèÿ ïðîôåññèîíàëüíûõ èíòîêñèêàöèé / Â.Ï. ×àùèí, Ã.È. Ñèäîðèè, Ë.Â. Ôðîëîâà [òà ³í.] // Ìåäèöèíà òðóäà è ïðîìûøëåííàÿ ýêîëîãèÿ. 2004. – ¹12. – Ñ. 10-12.

2. Ýëüáåêüÿí Ê.Ñ. Âëèÿíèå ìåëàòîíèíà íà áèîõèìè÷åñêèå ïîêàçàòåëè òîêñè÷íîñòè ñîëåé òÿæåëûõ ìåòàëëîâ ïðè âíóòðèáðþøèííîì ââåäåíèè êðûñàì / Ê.Ñ. Ýëüáåêüÿí // Òîêñèêî-ëîãè÷åñêèé âåñòíèê. 2006. – ¹1. – Ñ. 24-26.

3. Oberdorster G. Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains / G. Oberdorster // Inhal Toxicol. 2004. – 16 (6/7). – P. 461-471.

4. Duffin R. Pro-inflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity / R. Duffin, L. Tran, D. Brown, V. Stone, K. Donaldson // Inhal Toxicol. 2007. – Ð.849-856.

5. Ìåëüíèêîâà Í.Ì. Àì³íîêèñëîòíèé ñêëàä êðîâ³ ùóð³â îòðóºíèõ ð³çíèìè äèñïåðñíèìè ôîðìàìè ñâèíöþ / Í.Ì. Ìåëüíèêîâà, ².À. Íàçàðåíêî, ².À. Øåïåëüîâà // Á³îëîã³÷íèé â³ñíèê ÌÄÏÓ. 2012. – ¹1. – Ñ. 117-125.

6. Lewinski N. Cytotoxicity ofnanoparticles / N. Lewinski, V. Colvin, R. Drezek // Small. 2008. – Vol. 4 (1). – P. 26-49.

7. Marquis B. J. Analytical methods to assess nanoparticle toxicity / B.J. Marquis, S.A. Love, K.L. Braun, C.L. Haynes //Analyst. 2009. – Vol. 134 (3). – P. 425-439.

8. Ôåäîð³â Î.ª. ijÿ àöåòàòó ñâèíöþ íà ôîí³ ïèòíî¿ âîäè ç âì³ñòîì ñòåàðàò³â íàòð³þ òà êàë³þ íà ïðîöåñ ïåðåêèñíîãî îêèñíåííÿ ë³ï³ä³â â îðãàí³çì³ ï³ääîñë³äíèõ òâàðèí / Î.ª. Ôåäîð³â // Çäîáóòêè êë³í³÷íî¿ ³ åêñïåðèìåíòàëüíî¿ ìåäèöèíè. 2013. – ¹2 – Ñ. 202-207.

9. Êîíäðàòþê Â.À. Ñòàí àíòèîêñèäàíòíî¿ ñèñòåìè â îðãàí³çì³ ï³ääîñë³äíèõ òâàðèí ïðè ³çî-ëüîâàí³é ³ êîìá³íîâàí³é 䳿 àöåòàòó ñâèíöþ íà òë³ âæèâàííÿ âîäè ç âì³ñòîì ñòåàðàò³â íàòð³þ òà êàë³þ / Â.À. Êîíäðàòþê, Î.ª. Ôåäîð³â, Î.Â. Ëîòîöüêà, Ã.À. Êðèöüêà // Âîäà: ã³ã³º-íà ³ åêîëîã³ÿ. 2015. – ¹3-4 (3). – Ñ. 25-29.

10. ÄÑàíϳÍÓ 2.2.4-171-10 «Ã³ã³ºí³÷í³ âèìîãè äî âîäè ïèòíî¿, ïðèçíà÷åíî¿ äëÿ ñïîæèâàííÿ ëþäèíîþ».